Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional Booster Dose of RTS,S/AS01E in Malaria Challenge
NCT03824236Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2019
- Primary completion
- Apr 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of RTS,S in malaria (3 arms), sponsored by GSK. Primary endpoint: Number of Subjects Reporting Plasmodium Falciparum Parasitemia. Started Feb 2019; status: completed.
02
Drugs
RTS,S
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03824236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03824236.